Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq ... long-term analgesic effect in preclinical model of neuropathic pain, with no evidence of receptor desensitization TRV045 demonstrates ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
CHESTERBROOK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The supermodel and sustainability advocate showcases the label’s innovations in stretch denim with an edit of her favorite ...
In a recent move to streamline operations, Trevena (OTC:TRVN) Inc. has terminated the employment of three top executives as part of cost-cutting measures. On Monday, the pharmaceutical company's Board ...
TSHA Taysha Gene Therapies, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback